study question: Is there a different risk for major congenital anomalies (CAs) in children born after frozen-thawed embryo transfer (FET) compared with children born after fresh embryo transfer (ET)?
Introduction
Freezing and thawing of embryos is a well-established part of assisted reproductive technology (ART). Frozen embryo transfer (FET) has many advantages compared with the fresh embryo transfer (ET) procedure, and more importantly, it plays an essential role in single ET programmes. Several cohort studies have shown similar or even better perinatal outcomes for singletons after FET than those after fresh ET (Pelkonen et al., 2010; Pinborg et al., 2010; Sazonova et al., 2012) . However, a concern with FET is whether the cryoprotectants, freezing or thawing procedures have an adverse effect on the embryos and whether thereby cryopreservation processes increase the risk for major congenital anomalies (CAs).
In existing literature (Olson et al., 2005; Pinborg et al., 2010; Källén et al., 2010; Davies et al., 2012) children born after FET have not shown any significant difference in the risk for CAs compared with children born after fresh ET. However, one hospital-based study showed a higher CA rate in FET-ICSI children compared with fresh ICSI and FET-IVF children at 2 months of age (Belva et al., 2008) . These contradictory results are attributable to important aspects of data collection, such as different recruitment periods between the study groups, missing data on confounding factors, a lack of maternal background data and different definitions of CAs.
To provide further evidence of the safety on FET procedures we have performed a large cohort study to compare the prevalence of major CAs in keeping with the European Surveillance of Congenital Anomalies [European Concerted Action on Congenital Anomalies and Twins (EUROCAT)] in FET, fresh ET and naturally conceived births including pregnancy terminations for fetal CA. Our primary study hypothesis is that FET treatment is as safe as fresh IVF/ ICSI-ET treatment.
Materials and Methods
We performed a register-based cohort study that included children born after FET and fresh ET between the years 1995 -2006. This study is a continuation of our previous publication (Pelkonen et al., 2010) where we have described the details on obstetric and perinatal outcomes in the whole cohort identified from the registers of four Finnish infertility clinics. The population of the present study includes women who have undergone ART treatments with ET leading to singleton births (n ¼ 4772). A 10% random sample of women with spontaneous pregnancies from the Finnish Medical Birth Register (FMBR) served as the reference group (n ¼ 31 243). Multiple births (twins and triplets) were excluded: these comprised 463 FET children, of which 18 had CA, 1209 fresh ET children, of which 52 had CA and 703 reference group children, of which 24 had CA. Our focus was on major CAs in singleton births including 1830 children born after FET and 2942 children born after fresh ET.
The power analysis with data on all major CAs among newborns showed that with 5% alpha error level and power of 80%, the required sample size is 1925 to detect the current difference between cases and controls.
Our study data were compiled using the mothers' and the children's unique personal identification numbers (IDs) in linking the FMBR, the Register on Induced Abortions and Sterilizations (RIAS) and the Finnish Register of Congenital Malformations (RCM), all maintained by the National Institute for Health and Welfare (THL). IDs are extensively used in health-care services and all national registration systems. These unique numbers make it possible to follow-up the mothers and their children through the different national health registries.
The FMBR has been a nationwide statutory register since 1987, and it contains information on maternal background factors and on the outcomes of all live births and stillbirths with a gestational age of ≥22 weeks, or weighing ≥500 g, during the first 7 days (THL 2012b). The quality of the FMBR has been found to be high for the variables used in this study .
The RIAS has been a national statutory register since 1950s. The current legislation permits pregnancies to be terminated up to 20 weeks of gestation for social, medical or ethical reasons and up to 24 weeks of gestation in cases of a severe fetal disease or structural anomaly that has been detected by a reliable prenatal diagnostic method. Data on induced abortions are collected from all hospitals in Finland that perform induced abortions. The health-care unit performing the procedure is required to report the case to the National Institute for Health and Welfare (THL) within 1 month using a specific data collection form approved by the Ministry of Social Affairs and Health (THL 2012a) . The completeness of the register has been found to be good and the data reliable (Gissler et al., 1996) .
The RCM has been a nationwide statutory register since 1963. It collects information on all live births, stillbirths and selective terminations of pregnancy or spontaneous abortions with CAs. The data are collected through several data sources from hospitals, pathology departments and cytogenetic laboratories, and by linkages to several other nationwide health registers. CAs have been defined as major congenital structural anomalies, chromosomal defects and as a few other birth defects like congenital hypothyroidism and teratomas. CAs are classified and coded according to an extended version of the International Classification of Diseases, ICD-9. Minor anomalies are excluded principally according to the exclusion system of EUROCAT (www.eurocat.ulster.ac.uk). The RCM records all notified births/fetuses but only those with at least one major CA are considered malformation cases. There is no upper age limit for data collection but most cases are registered before the end of the second calendar year after birth or the termination of pregnancy (THL 2012c). Coverage and data quality of the RCM have been considered good in several studies (Pakkasjarvi et al., 2006; Leoncini et al., 2010) .
For this study only cases with major CAs, as defined in the RCM, were included in the analysis using organ system classification (ICD-9). A case was counted only once in each organ system, but a case with multiple major anomalies may appear in several different groups according to the organ systems affected. To obtain the total prevalence for CAs the medical geneticist responsible for the RCM reviewed all diagnosis and inclusion criteria, without information on the mode of conception of the births and fetuses from selective pregnancy terminations (n ¼ 33).
Research ethics and data protection
The study plan and the use of sensitive health register information in scientific research were approved by the National Research and Development Centre for Welfare and Health (STAKES, currently THL National Institute for Health Congenital anomalies after frozen embryo transfer and Welfare). For register linkages, the National Data Protection Authority was consulted, and permissions from the register keepers were obtained.
Statistical analyses
The differences between the FET group, the fresh ET group and the reference group were tested using the x 2 test. We calculated crude ORs for comparisons of the three groups. Breslow-Day test was used to study the homogeneity of the odds ratios (ORs) by sex, diagnosis and type of treatment. Statistical significance was defined as P , 0.05. Comparisons among the three study groups adjusted for children's year of birth and maternal age, parity and socioeconomic status (SES, measured from maternal occupation) were run using logistic regression. Smoking and SES are strongly correlated (Jaakkola et al., 2001) , and therefore we used SES in the logistic regression model. The results were displayed as unadjusted ORs and adjusted ORs (aORs) with 95% confidence intervals (CIs). A sub-analysis was also run comparing the ART groups (FET and fresh ET) versus the reference group and each subgroup (FET-IVF, FET-ICSI, IVF and ICSI) versus the reference group.
Results
As expected, the FET children were more likely to be born to older and multiparous mothers and as singletons than the children born after fresh ET. There were significantly fewer preterm births in FET than in fresh ET singletons. There were no significant differences between these two ART groups' socioeconomic position based on maternal occupation and smoking during pregnancy (Table I) . Among singleton births at least one major CA was reported in 77 cases (4.2%) in the FET group, in 132 cases (4.5%) in the fresh ET group and in 994 cases (3.2%) in the reference group (Table I ). In the sub-analysis, the highest birth prevalence of major CAs was in the FET-ICSI (5.1%) and the ICSI (5.0%) singletons (data not shown).The total prevalence of births and terminated pregnancies with CAs was 4.7% in the whole FET group and 4.9% in the whole fresh ET group (NS). During the study period the prevalence of terminated pregnancies for major fetal anomalies per all births did not differ between the ART groups (FET: n ¼ 13, 0.57% and fresh ET: n ¼ 20, 0.48%). The main indications for terminations in the ART groups are presented in Supplementary data, Table SI .
The crude number of major CAs in FET and fresh ET study groups and the numbers of CAs in specific organ systems are shown in Table II . In the adjusted analyses (Table III) the risk of having at least one major CA did not differ significantly between FET and fresh ET groups (aOR 0.95; 0.71-1.27). When inspecting the risk according to the different organ system affected, no increased risks were found between these two ART groups.
We compared the combined ART group with the reference group (Supplementary data, Table SII having at least one major CA was significantly higher in the children born after ART than in children born after spontaneous pregnancies (aOR 1.24; 1.05-1.47). When we studied specific organ systems, only the risk for urogenital anomalies was significantly higher in ART children (aOR 1.77; 1.18 -2.65). The homogeneity test was insignificant between these two study groups (data not shown). Only three cases with imprinting diseases were identified from the data. One child with Angelman syndrome was born after FET-IVF; two other children were from the reference group, one with Prader -Willi syndrome and one with Beckwith-Wiedemann syndrome (data not shown).
Discussion
The children born after FET did not appear to have a higher risk for major CAs than children born after fresh ET. As far as specific organ systems are concerned, no differences were shown between the FET and fresh ET children. However, the overall risk for CAs among ART children was moderately increased compared with ART children born after spontaneous pregnancies.
The first observation (Belva et al., 2008) on the differences between FET-ICSI and FET-IVF showed that the neonatal outcome results were otherwise comparable, except that there was a higher major CA rate in the FET-ICSI group, 6.4 versus 3.1% (OR 2.15; 95% CI 1.10 -4.20). More recently, Källén et al. (2010) conducted a larger study and could not verify this finding; they postulated that the finding may have been a result of multiple testing. So far, the largest population-based register study from Australia (Davies et al., 2012) showed higher CA rates among singletons' (FET-IVF 6.7% and FET-ICSI 7.7%) than in our study (3.9 and 5.1%, respectively) but neither study showed a significant difference between the methods of treatment. In the Australian study, the number of singleton births was lower than in our study, but they obtained information on these children up to 5 years. In our study, however, practically all major CAs were detected by the age of 1 year (99%) and registered in the Finnish RCM before the end of the second calendar year after birth (THL, 2012c) . The rates of pregnancy terminations in both studies are quite similar. We can postulate that the higher CA rate in FET births in the Australian study compared with ours can possibly be explained by the differences in definitions of the CAs, inclusions of the minor CAs and in the registration and health-care systems.
Our study populations are representative of the general population for these analyses. In the whole ART group we found a small but significantly increased risk for major CAs compared with our reference group with an aOR of 1.24 (1.05-1.47) confirming previous findings in the literature (Klemetti et al., 2005; Källén et al., 2010; Davies et al., 2012; Wen et al., 2012; Hansen et al., 2013; Pinborg et al., 2013) .
The strength of the study is that the information on all three study groups was extracted in an identical way from the RCM, which uses multiple data sources. The CAs were reviewed by a medical geneticist who was blind to the method of conception and ET status (frozen or fresh). To avoid detection and reporting bias, the major CAs are included principally according to the inclusion system of EUROCAT ensuring consistent, transparent and high-quality data (Loane et al., 2011) . In this study we were able to adjust for significant factors that can affect the results of CA studies, as presented by Källén et al. (2005) ; in addition, we had information on maternal SES. To minimize the bias arising from the long recruitment time, the mothers were matched for the year of delivery. Importantly, we studied pregnancy terminations for severe fetal Congenital anomalies after frozen embryo transfer anomalies to include all cases with CAs occurring in ART pregnancies in the final analysis. In the ART group the prevalence of pregnancy terminations for fetal anomalies was equal to that of the general Finnish population, 0.51 versus 0.40% (THL 2012c). Our study has some weaknesses; for example, we could not compare the data with a group of subfertile women to examine the effect of infertility per se on CAs. Previous studies have demonstrated (Basso and Olsen 2005; Zhu et al., 2006; Källén et al., 2010 ) that subfertility plays a significant role in the association between ART and CAs. Secondly, we were not able to differentiate the subgroups of FET using natural or hormonally substituted cycles. However, we suppose that the hormonal milieu during early weeks of pregnancy is more similar to that following natural conception during FET pregnancies than after fresh ET.
In conclusion, the perinatal outcome for FET children including their risk for CAs is good and comparable to that of other ART children, indicating that slow freezing is a safe method to use during ART treatments. This is important because we need a good and effective cryopreservation programme when implementing the single ET strategy. Our results are reassuring, but we have to keep in mind that the total number of studied FET births is still limited. Therefore, we need more controlled, large population-based studies to determine the occurrences and causes of infrequent outcomes like major CAs. When new ART technologies, including new culture media and freezing techniques, are incorporated into daily practice we need continuous surveillance programmes and updated research databases to prove their safety and to develop prevention strategies to reduce future ART children's risk of having unfavourable health outcomes. 
